337 related articles for article (PubMed ID: 16707625)
1. Transforming growth factor-beta receptor type 1 (TGFbetaRI) kinase activity but not p38 activation is required for TGFbetaRI-induced myofibroblast differentiation and profibrotic gene expression.
Kapoun AM; Gaspar NJ; Wang Y; Damm D; Liu YW; O'young G; Quon D; Lam A; Munson K; Tran TT; Ma JY; Murphy A; Dugar S; Chakravarty S; Protter AA; Wen FQ; Liu X; Rennard SI; Higgins LS
Mol Pharmacol; 2006 Aug; 70(2):518-31. PubMed ID: 16707625
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
3. Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor.
Bonniaud P; Margetts PJ; Kolb M; Schroeder JA; Kapoun AM; Damm D; Murphy A; Chakravarty S; Dugar S; Higgins L; Protter AA; Gauldie J
Am J Respir Crit Care Med; 2005 Apr; 171(8):889-98. PubMed ID: 15563636
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis.
Higashiyama H; Yoshimoto D; Kaise T; Matsubara S; Fujiwara M; Kikkawa H; Asano S; Kinoshita M
Exp Mol Pathol; 2007 Aug; 83(1):39-46. PubMed ID: 17274978
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways.
Pannu J; Nakerakanti S; Smith E; ten Dijke P; Trojanowska M
J Biol Chem; 2007 Apr; 282(14):10405-13. PubMed ID: 17317656
[TBL] [Abstract][Full Text] [Related]
6. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
Ponticos M; Holmes AM; Shi-wen X; Leoni P; Khan K; Rajkumar VS; Hoyles RK; Bou-Gharios G; Black CM; Denton CP; Abraham DJ; Leask A; Lindahl GE
Arthritis Rheum; 2009 Jul; 60(7):2142-55. PubMed ID: 19565505
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
Pannu J; Gardner H; Shearstone JR; Smith E; Trojanowska M
Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
[TBL] [Abstract][Full Text] [Related]
8. An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor β receptor.
Hoyles RK; Derrett-Smith EC; Khan K; Shiwen X; Howat SL; Wells AU; Abraham DJ; Denton CP
Am J Respir Crit Care Med; 2011 Jan; 183(2):249-61. PubMed ID: 20709822
[TBL] [Abstract][Full Text] [Related]
9. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.
Inman GJ; Nicolás FJ; Callahan JF; Harling JD; Gaster LM; Reith AD; Laping NJ; Hill CS
Mol Pharmacol; 2002 Jul; 62(1):65-74. PubMed ID: 12065756
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy.
Li J; Campanale NV; Liang RJ; Deane JA; Bertram JF; Ricardo SD
Am J Pathol; 2006 Nov; 169(5):1527-40. PubMed ID: 17071578
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
[TBL] [Abstract][Full Text] [Related]
12. Contribution of activin receptor-like kinase 5 (transforming growth factor beta receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts.
Chen Y; Shi-wen X; Eastwood M; Black CM; Denton CP; Leask A; Abraham DJ
Arthritis Rheum; 2006 Apr; 54(4):1309-16. PubMed ID: 16575856
[TBL] [Abstract][Full Text] [Related]
13. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.
Venkatesan N; Tsuchiya K; Kolb M; Farkas L; Bourhim M; Ouzzine M; Ludwig MS
Am J Respir Cell Mol Biol; 2014 Mar; 50(3):583-94. PubMed ID: 24127863
[TBL] [Abstract][Full Text] [Related]
14. Aortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathways.
Tumelty KE; Smith BD; Nugent MA; Layne MD
J Biol Chem; 2014 Jan; 289(5):2526-36. PubMed ID: 24344132
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of TGF beta receptor-triggered signaling cascades rapidly induced by the calcineurin inhibitors cyclosporin A and FK506.
Akool el-S; Doller A; Babelova A; Tsalastra W; Moreth K; Schaefer L; Pfeilschifter J; Eberhardt W
J Immunol; 2008 Aug; 181(4):2831-45. PubMed ID: 18684975
[TBL] [Abstract][Full Text] [Related]
16. The matricellular protein CCN1 enhances TGF-β1/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury.
Kurundkar AR; Kurundkar D; Rangarajan S; Locy ML; Zhou Y; Liu RM; Zmijewski J; Thannickal VJ
FASEB J; 2016 Jun; 30(6):2135-50. PubMed ID: 26884454
[TBL] [Abstract][Full Text] [Related]
17. Smooth muscle alpha-actin expression and myofibroblast differentiation by TGFbeta are dependent upon MK2.
Sousa AM; Liu T; Guevara O; Stevens J; Fanburg BL; Gaestel M; Toksoz D; Kayyali US
J Cell Biochem; 2007 Apr; 100(6):1581-92. PubMed ID: 17163490
[TBL] [Abstract][Full Text] [Related]
18. STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF.
Pechkovsky DV; Prêle CM; Wong J; Hogaboam CM; McAnulty RJ; Laurent GJ; Zhang SS; Selman M; Mutsaers SE; Knight DA
Am J Pathol; 2012 Apr; 180(4):1398-412. PubMed ID: 22322297
[TBL] [Abstract][Full Text] [Related]
19. Peptide-mediated inhibition of mitogen-activated protein kinase-activated protein kinase-2 ameliorates bleomycin-induced pulmonary fibrosis.
Vittal R; Fisher A; Gu H; Mickler EA; Panitch A; Lander C; Cummings OW; Sandusky GE; Wilkes DS
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):47-57. PubMed ID: 23470623
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta-induced alpha-smooth muscle cell actin expression in renal proximal tubular cells is regulated by p38beta mitogen-activated protein kinase, extracellular signal-regulated protein kinase1,2 and the Smad signalling during epithelial-myofibroblast transdifferentiation.
Sebe A; Leivonen SK; Fintha A; Masszi A; Rosivall L; Kähäri VM; Mucsi I
Nephrol Dial Transplant; 2008 May; 23(5):1537-45. PubMed ID: 18192325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
